Gene · 8021
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide Association Study and Rare Variant Association Studies of Strabismus in the All of Us Research Program. | Ophthalmol Sci | 2025 | 40837069 | PubTator, text mining | PubMed |
| Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma. | Blood Cancer J | 2025 | 40759639 | PubTator, text mining | PubMed |
| Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia. | Nat Commun | 2025 | 40730747 | PubTator, text mining | PubMed |
| A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia. | Clin Lymphoma Myeloma Leuk | 2025 | 40500616 | PubTator, text mining | PubMed |
| WDR62 affects the progression of ovarian cancer by regulating the cell cycle. | Hereditas | 2025 | 40369663 | PubTator, text mining | PubMed |
| DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes. | Leukemia | 2025 | 40204893 | PubTator, text mining | PubMed |
| XPO1-dependency of DEK::NUP214 leukemia. | Leukemia | 2025 | 40148556 | PubTator, text mining | PubMed |
| A case of T-cell acute lymphoblastic leukemia with co-occurrence of NUP214-ABL1 fusion and tetraploidy: A T-ALL case with NUP214-ABL1 fusion and tetraploidy. | Cancer Genet | 2025 | 40009976 | PubTator, text mining | PubMed |
| Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways. | Viruses | 2025 | 40006906 | PubTator, text mining | PubMed |
| Identification and Construction of a R-loop Mediated Diagnostic Model and Associated Immune Microenvironment of COPD through Machine Learning and Single-Cell Transcriptomics. | Inflammation | 2025 | 39798034 | PubTator, text mining | PubMed |
| Dysregulated genes in HIGK-treated F. nucleatum and their possible association with HNSCC. | Mol Biol Res Commun | 2025 | 39744516 | PubTator, text mining | PubMed |
| SET-NUP214-induced hypermethylation landscape promotes abnormal overexpression of HOXC cluster genes in acute megakaryoblastic leukemia. | Genes Dis | 2025 | 39634129 | PubTator, text mining | PubMed |
| The First Case Report of a Homozygous Consensus Acceptor Splice Variant in the NUP214 Gene Associated With Fetal Hydrops and Arthrogryposis Multiplex. | Cureus | 2024 | 39650934 | PubTator, text mining | PubMed |
Clinical features and long-term outcomes of pediatric patients with de novo acute myeloid leukemia in China with or without specific gene abnormalities: a cohort study of patients treated with BCH-AML 2005. | Hematology | 2024 | 39361146 | PubTator, text mining | PubMed |
| Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases. | Transpl Immunol | 2024 | 39233093 | PubTator, text mining | PubMed |
| Clinical, Phenotypic and Molecular Characterization of NUP214-ABL1 Fusion Positive Myeloid Malignancies. | J Med Cases | 2024 | 39205695 | PubTator, text mining | PubMed |
| [High-risk acute myeloid leukemia with DEK-NUP214 rearrangement and eyelid infiltration: a case report]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 38964929 | PubTator, text mining | PubMed |
| [Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 38951067 | PubTator, text mining | PubMed |
| Sacred Foe: About the Face of Exemplary Evil. | Int J Semiot Law | 2024 | 38948120 | PubTator, text mining | PubMed |
| Pre-ribosomal particles from nucleoli to cytoplasm. | Nucleus | 2024 | 38940456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8021/papers?page=2